| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a70309e0731990bc092117fdc17956b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2020-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6ab0e78f9ee05563878071899c03243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2b98632b7e719109ef60bb503bbab55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e71d4803deebc3c1b1a3c88e080f059d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63fdde0cb85820c1b2a513a756ba50fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4076d437bbf9ec3566e9ca5fc830c0ef |
| publicationDate |
2022-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220034769-A |
| titleOfInvention |
Alzheimer's disease biomarkers using blood samples from clinically diagnosed Alzheimer's disease subjects |
| abstract |
The present invention discloses a method of diagnosing Alzheimer's disease using biomarkers, and a multivariate assay that provides a more reliable and minimally or non-invasive detection method. The present invention relates to CD69 protein of mitotic lymphocytes, tau and phosphorylated tau protein, and amyloid-β peptide of cerebrospinal fluid, which can replace or complement existing detection methods of Alzheimer's disease, such as cognitive testing and amyloid-positron emission tomography. Simultaneous detection is initiated. |
| priorityDate |
2019-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |